ELDN compared with IMA: revenue, margins and what each company keeps, and the suppliers and customers both name

ELDNEledon Pharmaceuticals, Inc.

Mkt capRevenueRevenue

IMAImageneBio, Inc.

Mkt capRevenueRevenue

Compare

ELDNEledon Pharmaceuticals, Inc.

IMAImageneBio, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

ELDN, solidIMA, dashed

Supply-chain overlap

Revenue flow

ELDN: latest quarter not drawable. IMA: latest quarter is a loss; flow not drawable.Method ›

ELDNEledon Pharmaceuticals, Inc.

2.78▼−8.55%· post 2.83

Mkt cap$225.1MRevenue—

IMAImageneBio, Inc.

4.15▲+2.47%· post 4.15

ClosedOct 30 '26

Mkt cap$46.5MRevenue$800,000Q4 FY25

Compare

ClosedOct 30 '26

ELDNEledon Pharmaceuticals, Inc.

IMAImageneBio, Inc.

2.78▼−8.55%post 2.83

Price

4.15▲+2.47%post 4.15

$225.1M

Mkt cap

$46.5M

—

Revenue

$800,000Q4 FY25

ELDN2.78▼−8.55%vsIMA4.15▲+2.47%ClosedOct 30 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ELDN 1

NCELNewcelXsupplier

Shared 0

No shared counterparties.

Only IMA 3

—Hutchmedunlistedsupplier

—Wuxi Biologicsunlistedsupplier

—WuXi Biologics (Hong Kong)unlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR